2 March 2023

Spiritus Mundi plc

("Spiritus Mundi" or the "Company")

Appointment of Strategic Consultant

Spiritus Mundi plc (LSE: SPMU), the Special Purpose Acquisition Company (SPAC) which is seeking to acquire targets in Europe and Asia in the clinical diagnostics sector, is pleased to announce the appointment of Konstantinos ("Kon") Gryllakis as a strategic consultant to the Company.

Kon was until recently Head of Diagnostics, Asia Pacific, for Siemens Healthineers AG, the quoted global provider of healthcare solutions and services, owned 75% by Siemens AG, a role that he had fulfilled since 2015.  Kon has worked in the diagnostics sector since 1986, fulfilling a number of senior sales and management roles.  He was General Manager of Bayer Diagnostics (Australia and New Zealand) from 2003 to 2007, and CEO and President of Siemens Healthcare Diagnostics from 2007 to 2012.

Kon will be advising the Company on its business strategy and assisting with the sourcing and evaluation of potential acquisition targets in the laboratory and diagnostic testing sector.

Under the terms of his strategic consultancy agreement, Kon will be eligible to receive bonus payments and stock options on a successful reverse takeover by the Company which will be determined by reference to the enlarged Company's valuation at the time of its readmission.

Commenting, Zaccheus Peh, Non-Executive Chairman of Spiritus Mundi, said: "We are delighted that Kon has agreed to join the Spiritus Mundi team.  I expect his extensive experience and network of contacts in the clinical diagnostics sector will be of great value to the Company as we continue to look to identify and evaluate potential acquisition targets.  We are seeing a number of exciting potential opportunities and I look forward to providing further updates in due course."

For further information please contact:

Spiritus Mundi LEI: 213800DXMLNXMLCX4Q80